Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Diabetes. Apr 15, 2024; 15(4): 664-674
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.664
Figure 1
Figure 1 CONSORT flowchart. T2DM: Type 2 diabetes mellitus.
Figure 2
Figure 2 Mean glucose levels and mean glucose change (in mmol/L) after the consumption of rye bread and the special type of bread with TopiGluk® in diabetes mellitus type 2 patients and healthy subjects. A: Absolute values of glucose in diabetic patients; B: Glucose change from baseline in diabetic patients; C: Absolute values of glucose in healthy subjects; D: Glucose change from baseline in healthy subjects. aP < 0.05.
Figure 3
Figure 3 Insulin levels (µIU/L), median (25-75th percentile) and change after the consumption of rye bread and the special type of bread with TopiGluk® in diabetic patients. A: Absolute values; B: Change compared to baseline. bP < 0.05.
Figure 4
Figure 4 Insulin levels (µIU/L), median (25-75th percentile) and change after the consumption of rye bread and the special type of bread with TopiGluk® in diabetic patients. A: Absolute values in patients with oral antidiabetic therapy; B: Change compared to baseline in patients with insulin therapy; C: Change compared to baseline in oral antidiabetic therapy patients; D: Change compared to baseline in insulin therapy patients. aP < 0.05.